SANGAMO THERAPEUTICS, INC
Public company- Headquarters
- RICHMOND, California
- Industry
- Biotechnology
- Ticker
- SGMOQ
- CIK
- 0001001233
WARN notices since 2024
2
First: Jun 22, 2026
Workers affected since 2024
51
Across 2 notices
Executive changes, last 12 months
0
0 appointments, 0 departures
Last event
Jun 22, 2026
WARN noticeWARN notice: CA
Workers affected over time
Cumulative workers in WARN notices since 2024
| Notice date | Workers affected | Cumulative |
|---|---|---|
| Jun 22, 2026 | 4 | 4 |
| Jun 22, 2026 | 47 | 51 |
Leadership
No executive changes on record.
Related companies
Same industry and state, with recent events.
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
- AMGEN INC
director appointed: David W. Gibbs
- Cardiff Oncology, Inc.
CMO appointed: Leila Alland
- Vaxart, Inc.
member of the Board appointed: Raquel C. Bono, M.D., M.B.A., FACS
No events of this type on record.
Show all eventsLast verified Nov 8, 2026